Peter Rieckmann
Impact in
-
- Multiple Sclerosis Research Studies
-
- Medication Adherence and Compliance
Papers in
-
- Multiple Sclerosis Research Studies 18
-
- Stroke Rehabilitation and Recovery 1
- Co-authors
- Helen L. Tremlett (3 shared papers)Marcus Werner Koch (2 shared papers)Elaine Kingwell (2 shared papers)Per Soelberg Sørensen (7 shared papers)M. S. Freedman (1 shared paper)Bernd Sommerauer (1 shared paper)Ralf Gold (1 shared paper)Hans‐Peter Hartung (1 shared paper)
- Journals
- Multiple Sclerosis Journal (2 papers)Neurology (1 paper)Journal of Neurology Neurosurgery & Psychiatry (1 paper)Journal of Neurology (1 paper)Expert Opinion on Pharmacotherapy (1 paper)
- Partner nations
- GermanyCanadaUnited States
In The Last Decade
Peter Rieckmann
18 papers receiving 788 citations
Peers
Comparison fields: 5 of 46
- Pathology and Forensic Medicine 753
- Family Practice 8
- Neurology 11
- Neurology 17
- Immunology 21
Countries citing papers authored by Peter Rieckmann
This map shows the geographic impact of Peter Rieckmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Rieckmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Rieckmann more than expected).
Fields of papers citing papers by Peter Rieckmann
This network shows the impact of papers produced by Peter Rieckmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Rieckmann. The network helps show where Peter Rieckmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Rieckmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 410 | |
| 2 | 2010 | 201 | |
| 3 | 2008 | 89 | |
| 4 | Multiple Sclerosis Therapy Consensus Group (MSTCG) Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations | 2008 | 46 |
| 5 | 2022 | 22 | |
| 6 | 2012 | 16 | |
| 7 | 2010 | 14 | |
| 8 | Effects of cladribine tablets on peripheral lymphocyte subtypes implicated in multiple sclerosis immunopathogenesis: surface marker analysis for a subset of patients from the 96-week, phase III, double-blind, placebo-controlled CLARITY study | 2009 | 9 |
| 9 | 2001 | 8 | |
| 10 | Results from the CLARITY Study: a Phase III, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Oral Cladribine in Relapsing-Remitting Multiple Sclerosis (RRMS) | 2009 | 6 |
| 11 | 2022 | 5 | |
| 12 | 2023 | 4 | |
| 13 | Multiple Sclerosis Registry in Germany | 2008 | 3 |
| 14 | The CLARITY study (CLAdRIbine tablets Treating multiple sclerosis orallY): design of a Phase III trial of oral cladribine in relapsing multiple sclerosis | 2007 | 2 |
| 15 | 2004 | 1 | |
| 16 | MRI outcomes of short-course oral treatment with cladribine tablets for relapsing-remitting multiple sclerosis (RRMS) in the 96-week, phase III, double-blind, placebo-controlled CLARITY study | 2009 | 1 |
| 17 | Tolerability profile of cladribine tablets therapy for patients with relapsing-remitting multiple sclerosis: factors contributing to treatment completion overall and in patients with high disease activity in the 96-week CLARITY study | 2011 | 1 |
| 18 | 2025 | 1 | |
| 19 | Reconstitution of circulating lymphocyte subsets after treatment with cladribine tablets in the 96-week CLARITY study in relapsing-remitting multiple sclerosis | 2010 | 0 |
About Peter Rieckmann
Peter Rieckmann is a scholar working on Pathology and Forensic Medicine, Rehabilitation, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 19 papers that have together received 839 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (18 papers) and Stroke Rehabilitation and Recovery (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (753 citations), Family Practice (8 citations), Neurology (11 citations), Neurology (17 citations) and Immunology (21 citations). Peter Rieckmann has collaborated with scholars based in Germany, Canada and United States. Frequent co-authors include Helen L. Tremlett, Marcus Werner Koch, Elaine Kingwell, Per Soelberg Sørensen, M. S. Freedman, Bernd Sommerauer, Ralf Gold, Hans‐Peter Hartung, Klaus Victor Toyka and Reinhard Hohlfeld. Their work appears in journals such as Multiple Sclerosis Journal, Neurology, Journal of Neurology Neurosurgery & Psychiatry, Journal of Neurology and Expert Opinion on Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.